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Abstract
The categorization of intraductal proliferative lesions of the breast based on routine
light microscopic examination of histopathologic sections is in many cases
challenging, even for experienced pathologists. The development of computational
tools to aid pathologists in the characterization of these lesions would have great
diagnostic and clinical value. As a first step to address this issue, we evaluated the
ability of computational image analysis to accurately classify DCIS and UDH and to
stratify nuclear grade within DCIS. Using 116 breast biopsies diagnosed as DCIS or
UDH from the Massachusetts General Hospital (MGH), we developed a
computational method to extract 392 features corresponding to the mean and
standard deviation in nuclear size and shape, intensity, and texture across 8 color
channels. We used L1-regularized logistic regression to build classification models
to discriminate DCIS from UDH. The top-performing model contained 22 active
features and achieved an AUC of 0.95 in cross-validation on the MGH data-set. We
applied this model to an external validation set of 51 breast biopsies diagnosed as
DCIS or UDH from the Beth Israel Deaconess Medical Center, and the model
achieved an AUC of 0.86. The top-performing model contained active features from
all color-spaces and from the three classes of features (morphology, intensity, and
texture), suggesting the value of each for prediction. We built models to stratify
grade within DCIS and obtained strong performance for stratifying low nuclear
grade vs. high nuclear grade DCIS (AUC50.98 in cross-validation) with only
moderate performance for discriminating low nuclear grade vs. intermediate
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(AUC50.83 and 0.69, respectively). These data show that computational pathology
models can robustly discriminate benign from malignant intraductal proliferative
lesions of the breast and may aid pathologists in the diagnosis and classification of
these lesions.
Introduction
The pathological classification of ductal carcinoma in situ (DCIS) versus usual
ductal hyperplasia (UDH) on core biopsy of has major implications for patient
management. UDH is considered a benign proliferation, and patients with UDH
carry only a small increased risk of developing subsequent breast cancer compared
with patients without proliferative breast disease [1]. No treatment is necessary,
and clinical management includes the continuation of routine breast cancer
screening. In contrast, DCIS is a preinvasive malignant proliferation, and
approximately 25% of patients diagnosed with DCIS on core biopsy are found to
have invasive carcinoma upon surgical excision [2]. Primary treatment
recommendations for DCIS include lumpectomy with or without whole breast
radiation therapy and/or postoperative tamoxifen or total mastectomy with or
without sentinel lymph node biopsy [3]. Thus, DCIS patients receive aggressive
treatment, while UDH patients receive no treatment.
The pathological distinction of DCIS and UDH is based on multiple
architectural and cytologic features, with nuclear atypia being particularly
important in distinguishing the benign (UDH) from the malignant (DCIS)
lesions. Although the defining features of DCIS and UDH are well established, the
accurate and reproducible categorization of intraductal proliferative breast lesions
into these categories remains a challenge in many cases, even for experienced
pathologists [4–10]. The lack of reproducible and objective methods for
classifying intraductal proliferative lesions of the breast has clear negative
consequences, potentially resulting in both over- and under-treatment in clinical
practice and complicating the use of pathological diagnoses to guide research in
this area.
Given the importance of accurate and reproducible pathological diagnosis for
guiding clinical care and translational research, there would be value to the
development of computational tools to aid in the morphological characterization
of intraductal proliferative lesions. Descriptive morphological features of nuclear
atypia may be modeled with digitization of H and E-stained sections followed by
image processing and analysis. The process involves image capture via digital
photography or whole slide scanning [11], image segmentation via manual or
automated methods [12], the measurement of extracted features, and the
application of statistical methods to determine the association of features and
feature-based predictive models with pathological diagnosis or clinical outcome
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pathological findings in prior studies of mitotic activity [15,16] and epithelial
proliferations of the breast [
17–21]. In particular, the measurement of nuclear
area has been demonstrated to have diagnostic and prognostic value in malignant
and premalignant lesions [22–27].
Although the current literature demonstrates correlations between quantitative
features and proliferative breast lesions, this methodology has not yet been widely
adopted within the pathology community. One reason is due to the inconvenience
of applying previously published quantitative methods, which historically have
required significant manual intervention (e.g. for nuclear tracing) prior to the
measurement and extraction of one-to-several quantitative features of cellular
morphology. A second reason is few prior studies have used external validation
datasets, limiting our knowledge of the generalizability and robustness of the
findings. A third major challenge has been that few pathology laboratories have
possessed the requisite hardware and software for implementing computational
pathology algorithms, and thus, it has been challenging to translate research
advances to clinical practice. However, increasing numbers of laboratories are
acquiring whole slide imaging (WSI) platforms and digital pathology tools, which
should significantly facilitate the dissemination and ultimate clinical translation of
computational pathology algorithms [11,14,28,
29].
To build on the strengths and to address some of the limitations of prior work
in this area, we designed and implemented a computational pathology method for
the identification of nuclei and the quantification of nuclear features from
histological images of intraductal proliferative lesions of the breast. In this study,
we demonstrate the ability of this method to build classification models to
discriminate DCIS from UDH and to discriminate low grade from high grade
DCIS. These investigational tools provide new biological insights into the key
cellular phenotypic differences that differentiate UDH and DCIS and ultimately,
with further development, may provide real-time decision support to aid
pathologists in the interpretation of proliferative lesions of the breast. All image
processing code, images, and statistical code are provided at the accompanying
website: earlybreast.becklab.org.
Materials and Methods
Patient samples
Massachusetts General Hospital (MGH) Dataset
The study was approved by the Partners Human Research Committee (Partners
IRB), and the Partners IRB waived the need for consent. Cases were identified via
a search of breast biopsies with a diagnosis of DCIS or UDH at MGH. 80 cases of
DCIS and 36 cases of UDH from MGH were included in the study.
Core biopsy tissue was processed according to standardized laboratory
protocol. Formalin fixed and paraffin embedded (FFPE) tissue was cut into 5 mm
sections and stained with hematoxylin and eosin. The pathological grading of
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DCIS were graded as low, intermediate or high based on the degree of nuclear
atypia. If a case was reported to be intermediate between two grades, for the
purposes of this analysis we classified the case as the lower of the grades.
Beth Israel Deaconess Medical Center (BIDMC) Dataset
The study was approved by the Beth Israel Deaconess Medical Center IRB, and the
IRB waived the need for consent. Cases were identified via a search of breast
biopsies with a diagnosis of DCIS or UDH at BIDMC. 20 cases of DCIS and 31
cases of UDH from BIDMC were included in the study. Similar to the MGH data-
set, FFPE tissue was cut into 5 mm sections and stained with hematoxylin and
eosin. The pathological grading of DCIS cases were obtained from the diagnostic
pathology reports, and cases of DCIS were graded as low, intermediate or high
based on the degree of nuclear atypia. If a case was reported to be intermediate
between two grades, for the purposes of this analysis we classified the case as the
lower of the grades.
Image acquisition
One representative diagnostic hematoxylin and eosin stained slide per case was
digitized using Philips Ultra Fast Scanner 1.6 (Philips Digital Pathology; Best,
Netherlands) at 406 magnification with a resolution of 0.25 mm per pixel. Whole
slide images were reviewed, and diagnostic ROIs (1 to 4 per case) were manually
selected for image analysis. For cases with greater than 4 diagnostic foci, up to 4
regions with the highest cellularity were selected. The MGH cases were scanned
using a Philips Scanner at the MGH facility, while the BIDMC cases were scanned
using a Philips Scanner at BIDMC.
Image processing and feature extraction
The proposed image processing and analysis framework consists of three main
steps: nuclei segmentation, nuclei feature computation and statistical analysis and
machine learning on computed features.
Nuclei segmentation
Nuclei segmentation was performed using Fiji (ImageJ, National Institutes of
Health) [30]. For each image, the segmentation algorithm was applied for nuclei
segmentation. Initially, the RGB color image was converted into HSV color space,
in which image intensity (luma) is separated from color information (chroma),
which makes the HSV more closely match human perception. Color thresholding
was performed to obtain nuclear regions which were later processed with
morphological operations to fill holes and merge scattered nuclear regions.
Touching and overlapping nuclei were separated by watershed transformation.
Following nuclear segmentation, a size filter of 200–4000 pixels was applied to
exclude extracted objects of extremely small or large size to improve the specificity
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Fig. 1. Image processing of UDH (A), low grade DCIS (B), and high grade DCIS (C) includes conversion of hematoxylin and eosin-stained images
to binary images via automated threshold and watershed segmentation (D-F). Elliptical approximations of identified nuclear objects are shown (G-I).
Quantitative measurements (perimeter and circularity in this example) of nuclear distributions, where each data point represents one nuclear object, are
shown as scatterplots and contour plots of two-dimensional kernel density estimations for each case (J-L).
doi:10.1371/journal.pone.0114885.g001
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Fig. 1).
Nuclei feature computation
After nuclei segmentation, we computed morphological and statistical features
from the selected nuclear regions. The computed morphological features include
shape and geometric features, which are: area, perimeter, equivalent spherical
perimeter, bounding rectangle (width and height), fit ellipse (major and minor
axis), shape descriptors (circularity, aspect ratio, roundness and solidity) and
Feret’s diameter.
The statistical features are intensity based (first order) and texture based
(second order). We also explored the statistical features in different color models.
In order to study the specific information carried by the hematoxylin stain, which
highlights different cellular structures in the tissue, we separated hematoxylin and
eosin stains using color deconvolution [31]. Color deconvolution reduced the
problem of color variations in tissue appearance due to variation in tissue
preparation, stain reactivity from different batches, protocol and scanners. In
addition, different color models are proposed to separate a color into more useful
components that may bring new information to the system. In this framework,
our goal is to investigate the various color channels of different color models and
select those channels that produce the top-performing classification models. We
convert RGB images into two other color models, namely HSV (more intuitive for
human perception) and Lab and Luv (uniform color separation).
In H&E stained images, nuclear and cytoplasmic regions appear as hues of blue
and purple while extracellular material have hues of pink. In order to reduce the
influence of extracellular region intensity, the RGB images are transformed into a
new image called Blue-Ratio (BR) image to accentuate the nuclear dye [32] as:
BR~
100|B
1zRzG
|
256
1zRzGzB
where R, G and B are red, green and blue channels of RGB, respectively. In a BR
image, a pixel with a high blue intensity relatively to its red and green components
is given a high value, whereas, a pixel with a low blue intensity as compared to its
red and green components is given a low value. As we are interested in nuclei,
which appear as blue-purple areas, Blue ratio intensity indicates spatial
distribution of nuclear content in the image. For statistical feature computations,
we selected eight color channels; red, green and blue from RGB color model,
lightness (Value) from HSV color model, lightness from Lab and Luv color model,
BR grey scale image and Hematoxylin channel from H&E color deconvolution.
The first order statistical features determine the distribution of grey level values
within the nuclei regions. Using grey level information of the selected color
channels, we computed mean, median, standard deviation, skewness and kurtosis.
These five features were computed for each nucleus in selected eight color
channels, resulting in a total of 40 first order statistical features.
We computed two types of second order statistical features using grey level
Haralick co-occurrence [33] and run-length matrices [34]. The co-occurrence
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of grey levels in the image. The value at i
th and j
th column in the matrix is
produced by counting the total occasions a pixel with value i is adjacent to a pixel
with value j at a distance d and angle q. Then the whole matrix is divided by the
total number of such comparisons that have been made. Alternatively we can say
that each element of GLCM matrix is considered as the probability that a pixel
with grey level i is to be found with pixel with grey level j at a distance d and angle
q. We defined adjacency in four directions (vertical, horizontal, left and right
diagonals) with one displacement vector, which produced four GLCMs matrices.
In our case, texture information is rotationally invariant. So, we take the average
in all four directions and produce one GLCM matrix. Later, we compute 8
features proposed by Haralick from the GLCM in order to identify texture more
compactly. These eight features are correlation, cluster shade, cluster prominence,
energy, entropy, hara-correlation, homogeneity and inertia. These eight features
were computed for each nucleus in the selected eight color channels, resulting in a
total of 64 co-occurrence features.
The set of consecutive pixels, with the same grey level, collinear in a given
direction, constitute a grey level run length matrix GLRLM (i,j; q). The dimension
of GLRLM is Ng6R, where Ng is the number of grey levels and R is the maximum
run length. Similar to the GLCM, we compute GLRLMs for four directions and
later average them. The 10 run-length features, derived from GLRLM, are short
run emphasis (SRE), long run emphasis (LRE), grey-level non-uniformity (GLN),
run length non-uniformity (RLN), low grey level runs emphasis (LGLRE), high
grey level runs emphasis (HGLRE), short run low grey level emphasis (SRLGLE),
short run high grey level emphasis (SRHGLE), long run low grey level emphasis
(LRLGLE) and long run high grey level emphasis (LRHGLE). These features were
computed for each nucleus in the selected eight color channels, resulting in a total
of 80 run-length features. In total, we computed 196 texture features for each
nucleus.
Prior to statistical and machine learning-based analyses, feature measurements
were summarized at the patient level by computing the mean and standard
deviation of each feature per patient, producing a total of 392 summary features
per patient.
Statistical analysis and machine learning: We performed logistic regression with
Lasso regularization[35] to build multivariate image feature-based models to
classify DCIS versus UDH and low grade versus high grade DCIS. The analyses
were implemented in R (http://www.r-project.org/), using the glmnet[36] package.
Lasso regularization was used to create simpler models, less prone to overfitting,
than those that would be obtained from standard logistic regression. The Lasso
procedure consists of performing logistic regression with an L1 regularization
penalty, which has the effect of shrinking the regression weights of the least
predictive features to 0 [35]. The amount of the penalty (and the number of non-
zero features in the model) is determined by the regularization parameter l. This
method has been shown to perform well in the setting of colinearity[37] and has
been widely used to build predictive models from high-dimensional data in
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38–40]. Features were standardized separately in the
MGH and BIDMC data-sets prior to model construction, using the default setting
in glmnet. We evaluated model performance within the MGH data-set by 9-fold
cross-validation. For external validation on the BIDMC cases, we selected the
value of l that achieved the maximum AUC in cross-validation on the MGH
data-set and applied this fixed model to the BIDMC cases. Model performance
was assessed by computing the AUC.
Accompanying website
All images, image processing code, statistical code, and results are provided at the
accompanying website: http://earlybreast.becklab.org and data are deposited at the
Dryad database (http://dx.doi.org/10.5061/dryad.pv85m).
Results
Construction and evaluation of a computational pathology model
to discriminate DCIS from UDH
DCIS and UDH Analyses in the Massachusetts General Hospital Dataset
We performed L1-regularized logistic regression to construct classification models
to discriminate DCIS (n580) from UDH (n536). The top-performing model
contained 22 active features (Table 1) and achieved an AUC of 0.95 in cross-
validation (Fig. 2).
External Validation of the DCIS/UDH Classification Model
The most important test of a predictive model is its ability to generalize to new,
unseen data from an independent institution. Thus, we collected a set of 51
samples, containing cases of both DCIS (n520) and UDH (n531) as an external
validation dataset. We processed the samples in a similar fashion to that described
for the MGH samples. We trained the predictive model on the full MGH dataset
and applied the fixed model to the BIDMC dataset. On the BIDMC dataset, the
model showed strong classification performance, achieving an AUC50.86 (
Fig. 3). Later, we combined both training and validation datasets and performed
cross validation on all 167 cases, resulting in a model performance of AUC50.93 (
Fig. 4).
We next compared the performance of the DCIS vs UDH classifier on specific
grades of DCIS (Table 2) on the combined MGH and BIDMC datasets. The
resulting dataset contains UDH (n567), low grade DCIS (n529), intermediate
grade DCIS (n547) and high grade DCIS (n524) cases. We obtained strong
performance for building classifiers to discriminate UDH vs. high grade DCIS
(AUC50.97), UDH vs. low grade DCIS (AUC50.95), and UDH vs. intermediate
grade DCIS (AUC50.90). These results show that the DCIS vs. UDH classifier
performs well across all histologic grades of DCIS.
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obtained strong performance for low-grade vs. high grade DCIS (AUC50.98), but
only moderate performance for low grade vs. intermediate grade DCIS
(AUC50.83) and for intermediate grade vs. high grade DCIS (AUC50.69). These
results suggest the morphologic overlap between intermediate-and-low grade
DCIS and between intermediate-and-high grade DCIS.
Analysis of Features in the Top-Performing DCIS vs. UDH Model
The top-performing DCIS vs. UDH model contained a total of 22 features,
including intensity, morphology, and texture-based features (Table 1). Further,
features from all color spaces contributed to the top-performing model,
suggesting the added value of each.
Ablation analyses to compare performance of different feature classes and color
spaces
To identify the subset of most informative features, we performed ablation
analyses, in which we only consider a subset of features prior to model building
and evaluation. Of the feature classes, we obtained the strongest performance with
the texture features alone, which achieved an AUC of 0.91, followed by
morphology and intensity features alone (AUC50.89 and 0.85, respectively). Of
Table 1. Features and weights in the DCIS vs. UDH classification model.
Feature Name Summary Function Feature Class Color Space Weight
Mean_Variance_Red Mean Intensity Red (RGB) 0.000875
Mean_Kurtosis_Green Mean Intensity Green (RGB) 23.15038
Mean_Kurtosis_BR Mean Intensity BlueRatio 0.002031
Mean_Skewness_BR Mean Intensity BlueRatio 0.523952
SD_Mean_Red SD Intensity Red (RGB) 20.05881
SD_Variance_Green SD Intensity Green (RGB) 0.000543
Mean_Minor Mean Morphology N/A 20.13152
Mean_Round Mean Morphology N/A 228.1278
Mean_IDM_Blue Mean Texture Blue (RGB) 101.3997
Mean_ClusterShade_HSV Mean Texture V (HSV) 0.000004
Mean_GLN_Lab Mean Texture L (Lab) 20.074964
Mean_LGLRE_Lab Mean Texture L (Lab) 25239.083
Mean_SRLGLE_Lab Mean Texture L (Lab) 0.000001
Mean_LRLGLE_Lab Mean Texture L (Lab) 2329.1062
Mean_GLN_Luv Mean Texture L (Luv) 20.000184
Mean_LGLRE_Luv Mean Texture L (Luv) 20.058987
Mean_SRLGLE_Luv Mean Texture L (Luv) 235.01663
Mean_LRLGLE_Luv Mean Texture L (Luv) 20.563487
Mean_GLN_HE Mean Texture H (HE) 20.592543
SD_Inertia_Red SD Texture Red (RGB) 0.000525
SD_Entropy_Blue SD Texture Blue (RGB) 27.797402
SD_IDM_HSV SD Texture V (HSV) 289.83901
doi:10.1371/journal.pone.0114885.t001
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curve (AUC) based on predictions made on held-out cases in cross-validation with respect to log of the regularization parameter l (bottom) and the number
of features active in the model (top). Dotted lines indicate l of model with maximum AUC (left) and largest l such that the AUC is within one standard error of
the maximum (right). B. Receiver operating characteristic (ROC) curve based on predictions made in cross-validation for the l value that maximized the
AUC in cross-validation for discriminating DCIS vs UDH on the MGH dataset.
doi:10.1371/journal.pone.0114885.g002
Fig. 3. Validation of DCIS vs. UDH model on the BIDMC Dataset. A. Each point represents a case from the validation dataset. The cases are ranked
based on the probability of UDH, which is indicated on the Y-Axis. The red points represent cases of DCIS and the black points represent cases of UDH. B.
Receiver operating characteristic (ROC) curve based on based on predictions made on the BIDMC validation dataset for discriminating DCIS vs UDH.
doi:10.1371/journal.pone.0114885.g003
Image Analysis of Breast Intraductal Proliferations
PLOS ONE | DOI:10.1371/journal.pone.0114885 December 9, 2014 10 / 16the color channels, the red channel features achieved the highest performance
(AUC50.90), as compared with AUC50.89, 0.88 and 0.88 in the V (HSV), L
(Lab) and L (Luv) channels, respectively. No subset of features achieved as strong
performance as the full feature set (AUC50.93 in cross-validation), suggesting the
added value of each class of feature and color-space.
Discussion
Previous studies have used quantitative image analysis to aid in the histological
diagnosis and grading of breast lesions. Nuclear size and shape have been
associated with pathological findings such as tumor grade and necrosis in
malignant cytological and surgical breast specimens [17–20]. Morphometric
nuclear size measurements, including area, diameter, and short axis, have also
been associated with survival in patients with invasive carcinoma [22,23]. A
comprehensive machine learning-based analysis of invasive breast carcinoma
morphology has identified both epithelial and stromal features associated with
survival [38]. Two prior studies of male breast carcinoma have associated
morphometric parameters with tumor grade, immunohistochemical staining of
tumor-associated proteins, and clinical outcome [21,24].
Although relatively less work has focused on the evaluation of breast biopsies
with benign pathological diagnoses, nuclear morphometry in benign proliferative
lesions has been associated with the subsequent development of breast cancer
Fig. 4. Learning a logistic regression model to distinguish DCIS vs. UDH on the MGH and BIDMC Datasets. A. Area under the receiver operating
characteristic curve (AUC) based on predictions made on held-out cases in cross-validation with respect to log of the regularization parameter l (bottom)
and the number of features active in the model (top). B. Receiver operating characteristic (ROC) curve based on based on predictions made in cross-
validation for the l value that maximized the AUC in cross-validation for discriminating DCIS vs UDH on the MGH and BIDMC datasets.
doi:10.1371/journal.pone.0114885.g004
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ment to automated computational segmentation of cellular morphology, suggest
the value of developing and applying methods in quantitative image analysis to
link morphologic phenotypes with pathological diagnoses and clinical outcomes.
In contrast to most prior studies, we take a more unbiased data-driven
approach, where we develop automated image processing software to extract a
relatively high dimensional nuclear feature set (392 features) from each image and
then use machine learning-based methods to build models to predict pathological
diagnosis. Dundar et al. developed a morphometric pipeline to measure nuclear
perimeter, aspect ratio and mean gray level intensity across 62 training cases and
33 test cases of UDH, DCIS, and atypical ductal hyperplasia (ADH), and they
demonstrated an overall accuracy of 87.9% in distinguishing clinically actionable
from non-actionable lesions [
27]. This prior study and others have largely focused
on the quantitation of existing diagnostic criteria used by surgical pathologists for
disease classification. Our study builds on this approach and identifies novel
morphological features that are important in discriminating pathological
diagnoses of breast disease. Furthermore, our study demonstrates the ability for
Table 2. Classification performance for DCIS and UDH classification models across a range of classification tasks and using varying subsets of features.
Classification Performance, UDH vs. Grades of DCIS
Total Features Selected Features AUC
UDH vs High Grade DCIS 392 26 97
UDH vs Low Grade DCIS 392 29 95
UDH vs Intermediate Grade DCIS 392 46 90
Classification Performance, Between Grades of DCIS
Total Features Selected Features AUC
Low Grade vs High Grade DCIS 392 17 98
Low Grade vs Intermediate Grade DCIS 392 8 83
Intermediate Grade vs High Grade DCIS 392 37 69
Classification Performance, DCIS vs. UDH, with Different Subset of Features
Total Features Selected Features AUC
Textural Features 288 27 91
Morphological Features 24 16 89
Intensity Features 80 24 85
Classification Performance, DCIS vs. UDH, with Different Color Channels
Total Features Selected Features AUC
Red Channel 46 28 90
V (HSV) Channel 46 26 89
L (Luv) Channel 46 23 88
L (Lab) Channel 46 23 88
BlueRatio Image 46 21 85
Green Channel 46 31 84
Blue Channel 46 28 84
H (H&E) 46 37 82
doi:10.1371/journal.pone.0114885.t002
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two institutions using different histological protocols. This finding suggests that
these techniques may be implemented across multiple laboratories.
The image processing method could be further developed in several areas. First,
the current system requires expert selected regions of interest. The nuclear
detection algorithm currently implemented will not perform well on images that
are pure stroma and assumes that the image is selected to enrich for cells involved
in a breast epithelial proliferative lesion. A second area for future technical
development is incorporation of relational nuclear features (e.g. average distance
between nuclei, proportion overlapping nuclei) and spatial nuclear features (e.g.
nuclear streaming). A third area for future development is the inclusion of stromal
features into the predictive model. It is well known that DCIS may develop
reactive-type stroma, and this feature may have value in diagnosis and prognosis.
Lastly, performance may be further improved through the use of additional
machine learning methods, including convolutional neural networks, which have
recently shown strong performance for a range of image classification tasks
[41,42].
Despite these limitations, the current study represents a first step in applying a
computational pathology approach to the classification of intraductal prolifera-
tions of the breast. Our study demonstrates that models comprised of relatively
small sets of quantitative nuclear features can achieve high accuracy for the
classification of UDH vs. DCIS and low grade vs high grade DCIS. Building on
this work, we plan to extend the method to the analysis of additional challenging
intraductal proliferative lesions, including ADH, which represents a major
challenge in diagnostic pathology[9] and is an area where a computational
algorithm may be particularly useful for clinical practice.
With further development and validation, we envision this approach could be
incorporated into clinical practice in several ways. Today, the standard method
used to differentiate difficult cases on the borderline between low grade DCIS and
UDH is to perform immunohistochemistry (IHC) for estrogen receptor (ER) and
basal cytokeratins (CK5/6), with low grade DCIS tending to show the pattern of
ER positive and CK5/6 negative, while UDH shows a mosaic-staining pattern for
CK5/6 and variable ER positivity [43]. A computational pathology algorithm may
replace the need for IHC altogether in a subset of cases, resulting in increased
turnaround time and decreased cost, or alternatively, the algorithm may
supplement the use of IHC for difficult cases, providing another layer of evidence
to support one diagnosis or the other. In addition, we envision that a
computational pathology algorithm for intraductal proliferative lesions could
serve as a real-time second reader, which could point the pathologist to suspicious
lesions or could trigger the pathologist’s attention when the pathological diagnosis
disagrees with the computational interpretation, and in this way, the algorithm
could be used to identify cases requiring additional diagnostic work up.
The image processing algorithms, full set of images used in the analysis, and the
code for statistical analysis are made publicly available on the accompanying
Image Analysis of Breast Intraductal Proliferations
PLOS ONE | DOI:10.1371/journal.pone.0114885 December 9, 2014 13 / 16website (earlybreast.becklab.org) and data are deposited at the Dryad Database
(http://dx.doi.org/10.5061/dryad.pv85m).
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